Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
5.14
+0.37 (7.76%)
Nov 13, 2026, 4:00 PM EST - Market closed

Impact BioMedical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.0202000.05
Cash & Short-Term Investments
0.0202000.05
Cash Growth
75.00%-99.85%199800.00%-50.00%-95.65%-36.42%
Accounts Receivable
-0.01----
Other Receivables
---0.13--
Receivables
0.010.20.180.330.020.2
Inventory
0.060.06----
Prepaid Expenses
0.010.140.26-0.060
Other Current Assets
-00-0.040.04
Total Current Assets
0.10.412.450.330.120.29
Property, Plant & Equipment
--0.020.290.28-
Long-Term Investments
----0.784.82
Goodwill
---25.0925.0925.09
Other Intangible Assets
16.1416.9917.8118.9220.0321.15
Total Assets
16.4317.4120.2944.6346.556.43

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.450.350.310.830.540.12
Accrued Expenses
0.30.190.190.230.060.01
Short-Term Debt
--8.8812.079.9912.52
Other Current Liabilities
1.620.620.4---
Total Current Liabilities
2.371.169.7913.1410.5912.65
Long-Term Deferred Tax Liabilities
0.690.693.273.243.243.86
Total Liabilities
3.061.8513.0516.3713.8316.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.110.110.010.010.070.13
Additional Paid-In Capital
63.1562.0141.8638.1138.1138.06
Retained Earnings
-53.14-49.51-37.67-12.96-8.63-1.57
Total Common Equity
10.1212.614.225.1629.5636.61
Minority Interest
3.252.952.983.043.113.32
Shareholders' Equity
13.3715.567.2428.2632.6739.92
Total Liabilities & Equity
16.4317.4120.2944.6346.556.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--8.8812.079.9912.52
Net Cash (Debt)
0.020-6.88-12.07-9.99-12.48
Net Cash Growth
------
Net Cash Per Share
0.000.00-8.07-2.53-1.79-2.23
Filing Date Shares Outstanding
8.648.540.960.795.595.59
Total Common Shares Outstanding
8.548.290.910.795.595.59
Working Capital
-2.27-0.75-7.34-12.8-10.47-12.36
Book Value Per Share
1.181.524.6131.755.296.55
Tangible Book Value
-6.02-4.39-13.61-18.85-15.57-9.63
Tangible Book Value Per Share
-0.70-0.53-14.93-23.79-2.79-1.72
Machinery
--0.03-0.03-
Construction In Progress
----0.25-
SEC Filings: 10-K · 10-Q